Scientific Meeting Sponsorship supports scientific meeting organizers through Alpha-1 Foundation funding for AAT deficiency meetings, workshops, and conferences aligned with improving health and finding a cure.
Funder: Alpha-1 Foundation
Due Dates: September 25, 2026 (LOI) | February 12, 2027 (Full application) | At least two months before the meeting (Sponsorship requests)
Funding Amounts: Up to $5,000; support period depends on the request
Summary: Supports scientific meetings, workshops, and conferences relevant to alpha-1 antitrypsin deficiency and the Foundation’s mission.
Key Information: Contact Grants Administration Manager Vanessa Valencia before preparing a sponsorship request; industry applicants and collaborators are excluded.
The Alpha-1 Foundation’s Scientific Meeting Sponsorship supports meetings, workshops, and conferences relevant to alpha-1 antitrypsin (AAT) deficiency. It is listed within the Foundation’s 2026–2027 In-Cycle Grants Award Program, which supports meritorious work designed to improve the health of people with AAT deficiency and ultimately find a cure.
The sponsorship places scientific events within the Foundation’s broader commitment to advancing Alpha-1 treatment and care. Its research mission encompasses Alpha-1-related lung and liver disease, basic and clinical research, development of new therapies, and ethical, legal, and social issues affecting people with genetic conditions. Relevance to AAT deficiency and the Foundation’s mission is central to the meeting’s fit for support.